KEI Statement

KEI Oral Statement for US ITC Investigation on COVID-19 and TRIPS Agreement Flexibilities

Posted on by Claire Cassedy

NOTE: KEI also submitted a 16-page in depth written submission to this investigation on March 20, 2023. The US International Trade Commission (ITC) will hold a hearing on March 29-30, 2023 on COVID–19 Diagnostics and Therapeutics: Supply, Demand, and TRIPS… Continue Reading →

KEI Statement at WTO COVID-19 Vaccine Equity Event

Posted on by Claire Cassedy

On Wednesday April 14, 2021, the World Trade Organization hosted an event titled “COVID-19 and Vaccine Equity: What can the WTO contribute?” which featured three sessions concerning vaccine distribution, manufacturing, and looking forward at how the system could better address… Continue Reading →